MMRGlobal, Inc. (fka MMRF)

[Tulaz1]

MMR's Business Model Short-term, Medium-term, and Long-term

MMR - 4 business parts: PHR=$10/month per family, Esafe=$10/month per business professional EMR=$500/per doctor, biotechnology= from FVRL ($1M - $5M?? immediate cash upfront + shared revenue along each phase)

As of now MMR has only received revenue from 2 of these only in the US:
PHR - membership 500K since July 09 with an expected sharp increase until the EOY. (possible 1M mark) & Esafe is unknown at this point?

Future:

Short-Term:
China meetings involved Sanofi-Aventis & Medicilon/MPI for anti-cd20 which are "the world's most successful monoclonal antibodies". MMR is not in the business to cure cancer, but it has the technology to do it and can sell this to anyone willing to bid for it. This would include upfront cash and shared revenue along the way up. This deal could come at any time.

MMR has increased their membership significantly this year from deals made back in 2007. Because MMR sets up their Esafe and PHR to specifically meet the needs of affinity groups and companies it takes longer to set up and recieve revenue from it.
This post sums it up right here comparing deals by year:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=42289054

Medium-Term:
MMR Pro. Hands down the greatest thing I have ever heard of. The real reason I put down as much as I have on one stock. Set to release in Jan 2010 MMR Pro is the cheapest EMR (20K over 3 years compared to $50K per year competition and it does not change what the doctor does in the office, yet still will upload all of their files digitally and make them available to anyone they choose(lab, pharmacist, insurance company, etc.)via fax or email with a click of a mouse. On top of that it is the easiest to use(no setup of clunky machinery that will crowd an office), its the safest(1M insurance policy), + MMR Pro has its PHR built into it and will give doctors the ability to sell upgrades to their patients so that the whole family's medical records can be in one place and can be used with multiple doctors(dentist, specialist,etc). This lets doctors sell PHR's and MMR will share revenue with them when they do.

Long-Term:
China and beyond. Deal made today in China is a monopoly. There is no technology like this there and any technology that comes after this will be built on top of MMR's. MMR has interoperability(the real reason this company is in debt at this point). This means that MMR will serve as the storgage facility for these medical files and will be able to work along with other types of EMRs as long as they produce an image or a document - which every EMR at this point does.

MMR the only bi-lingual and soon to be tri-lingual PHR/EMR in the market -they will be adding their products to Spain, Japan, Mexico, etc. in the future.

Any Phase I, Phase II by this time with the biotechnology will add to the already core components of the business.

If you do enough DD on the management you will see this is not another flimsy penny stock. The potential is here, but the management surpasses anything and everything else.

~T~